FundRx
Venture capitalPalo Alto · Pre-Seed–Seed
Investment thesis
FundRx invests in early-stage companies advancing deep health innovation across multiple therapeutic and diagnostic domains. The firm's portfolio spans synthetic biology, AI-driven drug discovery and clinical workflows, novel therapeutics including psychedelics and novel formulations, reproductive health, preventive medicine, and health infrastructure solutions. The investment thesis prioritizes scientific rigor and the potential to meaningfully improve health outcomes at scale, particularly in areas addressing unmet medical needs and health equity gaps.
Source: firm website, verified Aug 6, 2026.
What they invest in
from 1 of 2 portfolio companiesAI & Machine Learning ×1Digital Health ×1Healthtech ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathBuoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.
AI & Machine LearningDigital HealthHealthtechBoston, US
Andrew Le(Executive Officer, Director, Promoter)Andrew Le, MD(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)
Co-investorsEvolution VC PartnersF-Prime CapitalTorch CapitalHumanaOptum VenturesWR Hambrecht
Osmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Co-investorsFelicis VenturesFigure 8 InvestmentsGreycroftMaryland TEDCOMichelson 20MM FoundationSocial Starts+1 more
Portfolio news
latest coverage across their companiesOsmosis · osmosisim.com · Feb 23, 2026
Frequently asked questions
- What stage does FundRx invest at?
- FundRx invests at the Pre-Seed, Seed stages.
- What sectors does FundRx focus on?
- FundRx focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is FundRx located?
- FundRx is headquartered in Palo Alto, US.
Similar investors
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Altitude Life Science Ventures invests in early-stage life science companies operating in markets with strong demand and growth potential, backing high-quality teams to build durable businesses.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Dolby Family Ventures is an investment firm focused on life sciences, backing companies across precision neuroscience and life sciences platforms.
Legend Star is an early-stage angel investment firm based in China that backs entrepreneurs and also runs an entrepreneur training program (Startup CEO training class) and an entrepreneur alliance.